 |
|
Dose-Related Ethanol-like Effects of the NMDA Antagonist, Ketamine, in Recently Detoxified Alcoholics
John H. Krystal, MD;
Ismene L. Petrakis, MD;
Elizabeth Webb;
Ned L. Cooney, PhD;
Laurence P. Karper, MD;
Sheila Namanworth;
Philip Stetson, PhD;
Louis A. Trevisan, MD;
Dennis S. Charney, MD
Arch Gen Psychiatry. 1998;55:354-360.
Background This study evaluated the dose-related ethanol-like subjective effects of the N -methyl-D-aspartate (NMDA) glutamate receptor antagonist ketamine hydrochloride in recently detoxified alcoholics.
Methods Twenty male inpatients meeting DSM-III-R criteria for alcohol dependence and who had not consumed alcohol for 10 to 27 days prior to the study completed 3 test days that involved the intravenous infusion of ketamine hydrochloride (0.1 mg/kg or 0.5 mg/kg) or saline solution under randomized double-blind conditions. Ethanol-like subjective effects were assessed using the Sensation Scale; the Biphasic Alcohol Effects Scale; visual analog scales to measure "high" and degree of similarity to ethanol, cocaine, and marijuana; a scale assessing the number of standard alcohol drinks producing similar subjective effects; and visual analog scales measuring ethanol craving.
Results Ketamine produced dose-related ethanol-like effects on each scale measuring its similarity to ethanol. Its effects were more similar to the sedative or descending limb effects of ethanol than to the stimulant or ascending limb effects. Ketamine effects also were more like ethanol than marijuana or cocaine. Ethanol-like effects were more prominent at the higher ketamine dose, a dose rated as similar to greater levels of ethanol intoxication. However, ketamine did not increase craving for ethanol.
Conclusion The production of ethanol-like subjective effects by ketamine supports the potential clinical importance of NMDA receptor antagonism among the mechanisms underlying the subjective effects of ethanol in humans.
From the Department of Psychiatry, Yale University School of Medicine and the Veterans Affairs–Yale University Alcoholism Research Center, West Haven, Conn (Drs Krystal, Petrakis, Cooney, Karper, Trevisan, and Charney and Mss Webb and Namanworth); and the Upjohn Research Institute, Department of Pharmacology, University of Michigan Medical School, Ann Arbor (Dr Stetson).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Orphan Transporter Rxt1/NTT4 (SLC6A17) Functions as a Synaptic Vesicle Amino Acid Transporter Selective for Proline, Glycine, Leucine, and Alanine
Parra et al.
Mol. Pharmacol. 2008;74:1521-1532.
ABSTRACT
| FULL TEXT
The Role of Protein Kinase A in Acute Ethanol-Induced Neurobehavioral Actions in Rats
Lai et al.
Anesth. Analg. 2007;105:89-96.
ABSTRACT
| FULL TEXT
Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients
Krupitsky et al.
Am. J. Psychiatry 2007;164:519-523.
ABSTRACT
| FULL TEXT
Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function
Krystal et al.
Arch Gen Psychiatry 2005;62:985-994.
ABSTRACT
| FULL TEXT
Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism
Petrakis et al.
Am. J. Psychiatry 2004;161:1776-1782.
ABSTRACT
| FULL TEXT
Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists
Anand et al.
Arch Gen Psychiatry 2000;57:270-276.
ABSTRACT
| FULL TEXT
Dextromethorphan Challenge in Alcohol-Dependent Patients and Controls
Schutz et al.
Arch Gen Psychiatry 2000;57:291-292.
FULL TEXT
Novel Uncompetitive N-Methyl-D-Aspartate (NMDA)-Receptor Antagonist MRZ 2/579 Suppresses Ethanol Intake in Long-Term Ethanol-Experienced Rats and Generalizes to Ethanol Cue in Drug Discrimination Procedure
Hölter et al.
J. Pharmacol. Exp. Ther. 2000;292:545-552.
ABSTRACT
| FULL TEXT
Ethanol Inhibition of N-Methyl-D-aspartate Receptors Is Reduced by Site-directed Mutagenesis of a Transmembrane Domain Phenylalanine Residue
Ronald et al.
J. Biol. Chem. 2001;276:44729-44735.
ABSTRACT
| FULL TEXT
|
